Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell

Xaira Therapeutics releases 8 million cell dataset

The unicorn biotechnology startup Xaira Therapeutics, co-founded by 2024 Nobel Prize winner David Baker, has released what it claims is the largest public genome-wide Perturb-seq dataset to date. Freely available, the data is available as a 520 GB download and comes with an associated pre-print. Comprising eight million cells, the X-Atlas/Orion dataset dwarfs previous public… The post Xaira releases 8-million-cell map of gene functions to fuel A…

Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell

Ever since artificial intelligence (AI) drug developer Xaira Therapeutics launched in April 2024 with a jaw-dropping $1 billion in committed capital and a star-studded leadership lineup—including David Baker, PhD, the 2024 Nobel Laureate in Chemistry and University of Washington/HHMI investigator, Carolyn Bertozzi, PhD, the 2022 Nobel Laureate in Chemistry, Stanford University, Scott Gottlieb, MD, former FDA head, Alex Gorsky, former CEO of John…

After a quiet year, Xaira unwraps some of its AI research, eyeing a virtual cell

Last spring, Xaira Therapeutics launched with over a billion dollars, a star-studded team and big dreams to remake R&D with AI. The South San Francisco-headquartered startup has been fairly quiet since its ...